Carcinomatous Edema

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2021-03-18
Clinical Trial Update: A Multicenter, Open-label, Dose-finding Trial of OPC-41061 to Investigate Efficacy, Pharmacokinetics, Pharmacodynamics, and Safety in Patients With Carcinomatous Edema (Phase 2) [Phase 2]
Phase 2 open-label dose-finding trial evaluating OPC-41061 in carcinomatous edema has completed with results posted.